Marathon Trading Investment Management LLC Aquestive Therapeutics, Inc. Transaction History

Marathon Trading Investment Management LLC

$201 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 12, 2024	SELL	$2.31 - $4.5 $165,800 - $322,987	-71,775 Reduced 79.75%	18,225 $47,000
Q1 2024 May 10, 2024	BUY	$2.01 - $6.09 $180,899 - $548,100	90,000 New	90,000 $383,000

Others Institutions Holding AQST

# of Institutions

122

Shares Held

46.8M

Call Options Held

517K

Put Options Held

207K

Bratton Capital Management, L.P. Fort Worth, TX

9.81M
Shares

$45 Million
100.0% of portfolio
Vr Adviser, LLC New York, NY

5.56M
Shares

$25.5 Million
2.87% of portfolio
Black Rock Inc. New York, NY

5.45M
Shares

$25 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.26M
Shares

$19.6 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

2.77M
Shares

$12.7 Million
0.0% of portfolio

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $245M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account